Issue
Title
Authors
No 3 (2019)
Inflationary processes in the pharmaceutical market: development forecasting
Livansky S.M., Utyomova A.S., Denisova M.N.
PDF
(Rus)
No 10 (2019)
Key trends in the mucoactive drugs market
Prozherina Y.
PDF
(Rus)
No 4 (2024)
The review of the Russian biotech drugs market
Khalimova A.A., Trofimova E.O., Orlov A.S.
PDF
(Rus)
No 1 (2024)
Prospects for development of the domestic hemostatic drugs market based on analysis of B02BC group sales
Kozhevnikova V.A., Grishina M.G.
PDF
(Rus)
No 2 (2023)
Monitoring information on the safety of antibacterial and anti-tuberculosis drugs
Egiazaryan E.A., Kosova I.V.
PDF
(Rus)
No 1 (2025)
Analysis of demand and supply of cholesteric drugs in the pharmaceutical market
Айдова А.В., Шакирова Д.Х., Сафиуллин Р.С., Абдулхаков С.Р.
PDF
(Rus)
No 12 (2018)
The role of the clinical pharmacist-in-charge in inter-professional collaboration: a view of specialists from different countries
Chukreeva N.V., Maksimkina E.A.
PDF
(Rus)
No 4 (2019)
PRESCRIPTION DRUG INSURANCE: CHOOSING A PATH
Popovich L.D.
PDF
(Rus)
No 2 (2023)
Production of domestic drugs in the first period of the Great Patriotic War
Камельских Д.В., Серебряный Р.С.
PDF
(Rus)
No 6 (2018)
Pharmaceutical industry for Q I, 2018
Romanova S.
PDF
(Rus)
No 9 (2020)
Comparison and analysis of the fda approved orphane drugs register and the vital and essential drugs list of the Russian Federation
Yurochkin D.S., Leshkevich A.A., Golant Z.M., Narkevich I.A.
PDF
(Rus)
No 1 (2022)
Features of drug provision in palliative care
Volkova N.S.
No 11 (2019)
Construct validation and reliability analysis of a questionnaire to evaluate the factors influencing pharmacy staff's recommendation of over-the-counter drugs in Vietnam
Tran V.D., Dorofeeva V.V., Lagutkina T.P.
PDF
(Rus)
No 1 (2025)
Potent drugs: legal significance, assortment
Tarasevich V.N., Novikova N.V., Lyskova T.L.
PDF
(Rus)
No 12 (2018)
Analysis of patent portfolios of anticancer drugs
Viukhin M., Shulgin V., Bushueva M.
PDF
(Rus)
No 2 (2023)
Current issues of medicines disposal from pharmacy organizations
Sharapov S.S.
PDF
(Rus)
No 6 (2018)
Rational drug therapy of ulcerative colitis: meta-analysis and clinical and economic aspects of modern therapy regimens
Shatalova O.V., Gorbatenko V.S.
PDF
(Rus)
No 7-8 (2020)
The electronic common technical documentformat as the basis for a single pharmaceutical market of the Eurasian Economic Union
Taube А.А., Levashova A.Y.
PDF
(Rus)
No 4 (2021)
Economic overview of the Russian pharmaceutical market during the pandemic crisis
Bazhenova S.A., Grammova E.A.
No 10 (2019)
Analysis of the Russian paediatric antibacterials market
Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Ladut'ko Y.M., Terninko T.M., Zagalov D.E., Mikhaylova Y.V.
PDF
(Rus)
No 4 (2024)
Clinical — economic indicators of the effectiveness of pharmacotherapy in two different therapy for psoriasis vulgaris
Khokhlov A.L., Samarina E.I., Lileeva E.G.
PDF
(Rus)
No 12 (2018)
Advertising in the pharm market: evaluation of 2018 practice and forecasts for self-regulation
Borzova M.
PDF
(Rus)
No 1-2 (2019)
Changes in VED list: an opportunity that came true
Prozherina J., Shirokova I.
PDF
(Rus)
No 1 (2023)
Methodological bases of ensuring the safety of drugs in the process of their storage (on the example of the Republic of Tajikistan)
Михайлова В.Н., Хомидов Д.К., Кирщина И.А., Березина Е.С.
PDF
(Rus)
No 6 (2018)
«May» prospects for Russian pharma market
Trofimova Е.О.
PDF
(Rus)
No 4-6 (2020)
Medical device manufacturing: results of 2019
Romanova S.
PDF
(Rus)
No 4 (2021)
Development of proposals for improving the processes of circulation of extemporal drugs and regulation of prescription and production activities of pharmaceutical organizations in the Russian Federation
Narkevich I.A., Golant Z.M., Yurochkin D.S., Leshkevich A.A., Erdni-Garyaev S.E.
No 11 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 11-12 (2020)
Agile stockpiles an insurance for drug supply
Gilissen E., Mulligan C., Tottman S., Troein P.
PDF
(Rus)
No 1 (2023)
Applications of some biodegradable polymers in medicine
Abbasov I.B.
PDF
(Rus)
No 6 (2018)
Drug labelling: experience of implementation and prospects
Slinyakov Е.Е.
PDF
(Rus)
No 3 (2021)
Study of the availability of gene therapeutic drugs in the Russian Federation
Koshechkin K.A., Romanov P.A., Mokhov A.A., Khokhlov A.L.
PDF
(Rus)
No 4 (2021)
Building a logical-semantic model of the choice of fixed combinations of drugs for treatment of hypertension
Ibragimova G.Y., Fedotova A.A., Iksanova G.R., Khasanova R.Y., Vasilchenko K.A.
No 9 (2019)
Dementia drugs market analysis in Russia
Trofimova Е.О., Izvekov N.V.
PDF
(Rus)
No 1 (2024)
Analysis of drug safety risk factors in medical organizations of Moscow in 2020 2022
Kuznetsova E.V., Zhuravleva M.V., Mikhailov I.A., Khabriev R.U.
PDF
(Rus)
No 11 (2018)
Road map and BAA market: forecasts and risks
Borzova M.
PDF
(Rus)
No 10 (2020)
Pharmaceutical industry in the first half of 2020
Romanova S.
PDF
(Rus)
No 1 (2023)
Comparative analysis of temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection
Motygullina L.I., Tukhbatullina R.G.
PDF
(Rus)
No 5 (2018)
Investment activity of pharmaceutical enterprises: 9 months of 2017
Romanova S.
PDF
(Rus)
No 3 (2021)
A structural analysis of sales of drugs for the treatment of chronic hepatitis C in the Russian market
Tsitlionok E.A., Narkevich I.A., Nemyatykh O.D., Siukaeva D.D., Grinyuk A.S., Lisachenko V.O.
PDF
(Rus)
No 13S (2018)
Main trends in the Moscow labor market in medicine and pharmaceutics in 2017
Ignatova M.
PDF
(Rus)
No 9 (2019)
Development of the rare (orphan) drug market
Yurochkin D.S., Golant Z.M., Narkevich I.A.
PDF
(Rus)
No 10 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 10 (2020)
AnviMax®: optimal drug to combat ARVI and influenza
Kalinina N.
PDF
(Rus)
No 1 (2023)
Pharmaceutical enterprises in the first period of the Great Patriotic War in the USSR
Serebryany R.S., Kamelskikh D.V.
PDF
(Rus)
No 5 (2018)
Russian pharmaceutical market at the first quarter-end 2018
Denisova M., Prozerina J.
PDF
(Rus)
No 1 (2021)
Investment activity of pharmaceutical enterprises:intermediate results for 2020
Romanova S.
PDF
(Rus)
No 13S (2018)
Top drugs of the Russian pharmaceutical market in 2017
Article E.
PDF
(Rus)
No 7-8 (2019)
Priority needs in creating restricted drug lists in Russia. Feasible approach
Kolbin A.S., Maksimkina E.A., Mishinova S.A.
PDF
(Rus)
No 4 (2023)
The development of the Russian pharmaceutical market at the beginning of the XXI century. Price trends and key factors.
Denisova M.N.
PDF
(Rus)
No 10 (2018)
Regulatory aspects of the introduction of the drug therapy outcomes-based payment concept
Tolkushin A.G., Fedorov A.A., Yagudina R.I., Davydovskaya M.V., Chernitskaya M.K., Ermolaeva T.N., Kobzeva N.V., Kokushkin K.A.
PDF
(Rus)
No 10 (2020)
Pharmacy market for 9 months 2020: coronavirus and digital
Kalinina N.
PDF
(Rus)
No 3 (2022)
Analysis of the budget expenditure for rare diseases in the subjects of the Russian Federation
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 5 (2018)
Analysis of development trends of the pharmaceutical market of non-steroidal anti-inflammatory drugs in Russia
Oleynikova T.A., Pozhidaeva D.N.
PDF
(Rus)
No 1 (2021)
New old trends. Advertising practice
Borzova M.
PDF
(Rus)
No 13S (2018)
Analysis of the FFP Tender Market in 2017
Article E.
PDF
(Rus)
No 7-8 (2019)
Exclusive rights protection practice in the pharmaceutical sector and trends of its development
Borzova M.
PDF
(Rus)
No 4 (2023)
Accessibility of medical care for adult cancer diseases using off-label drugs: clinical recommendations and standards of medical care analysis
Ledovskikh Y.A.
PDF
(Rus)
No 10 (2018)
New immunization level
Shirokova I.
PDF
(Rus)
No 10 (2020)
Innovative medicines on the Russian pharmaceutical market:key players and main directions of development
Chaplenko A.A., Vlasov V.V., Gildeeva G.N.
PDF
(Rus)
No 2 (2022)
“New” rare diseases and budget deficiency: is the problem “great”?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 4 (2018)
Risk sharing schemes based on cost-effectiveness of multiple sclerosis disease modifying drugs: foreign experience and the possibilities of its use in Russia
Tolkushin A.G., Kholovnya-Voloskova M.E., Andreev D.A., Khachanova N.V., Ermolaeva T.N., Davydovskaya M.V., Kokushkin K.A.
PDF
(Rus)
No 1 (2021)
Management by objectives method in the government support arrangements for the public pharmacare system
Tarabukina S.M., Dremova N.B.
PDF
(Rus)
No 13S (2018)
Russian pharmaceutical market: results and forecasts
Article E.
PDF
(Rus)
No 5 (2019)
Methodical approaches to the development of the structural-logical scheme of personalized therapeutic drug management for cancer patients
Tarabukina S.M., Moshkova L.V., Chertovskikh Y.V.
PDF
(Rus)
No 2 (2023)
Market analysis of drugs for the treatment of osteoporosis and prospects for its development in the Russian Federation
Alekseeva V.A., Krikova A.V.
PDF
(Rus)
No 10 (2018)
The role of modern herbal remedies in the management of cough
Prozherina J.
PDF
(Rus)
No 9 (2020)
Investment activity of pharmaceutical enterprises: 2019
Romanova S.
PDF
(Rus)
No 2 (2022)
Marketing analysis of the range of medicines for physiotherapy
Shubina K.A., Shakirova D.H.
PDF
(Rus)
No 3 (2018)
Key trends of the antiparkinsonian drugs market
Prozherina J.
PDF
(Rus)
No 1 (2021)
In combat against viruses
Shirokova I., Prozherina Y.
PDF
(Rus)
No 12 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 5 (2019)
Nomenclature of gene-therapy drugs: international experience
Mokhov A.A., Merkulov V.A., Melnikova E.V., Popov P.I., Dudchenko V.V., Koshechkin К.А., Chaplenko A.A., Yavorsky A.N.
PDF
(Rus)
No 9 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 9 (2020)
Symptomatic Slow-Acting Drugs (SYSADOA) is the new reality in the treatment of osteoarthritis
Prozherina Y.
PDF
(Rus)
No 1 (2022)
Rare diseases in the subjects of the Russian Federation: are these patients rare?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
No 12 (2019)
If you can’t breathe through your nose
Kalinina N.
PDF
(Rus)
No 2 (2021)
Pharmaceutical industry for 2020
Romanova S.
PDF
(Rus)
No 3 (2025)
The peculiarities of the consumption structure of oral hypoglycemic drugs in rural areas of the Lugansk People's Republic
Chukarina Y.V., Perederii E.A.
PDF
(Rus)
No 12 (2018)
Gender peculiarities of the consumer behavior in the gastroenterological drugs market
Ermolaeva A.D., Lobutev L.A., Krivosheev S.A.
PDF
(Rus)
No 4 (2019)
ANALYSIS OF PATENT PORTFOLIOS IN THE ANTI-INFLUENZA DRUG SEGMENT
Vyukhin M., Rodnin A., Shulgin V.
PDF
(Rus)
No 2 (2023)
Features of modeling the course and outcomes of diseases in the clinical and economic analysis of drugs in oncology — a review of the models used
Tolkushin A.G., Khabriev R.U.
PDF
(Rus)
No 7-8 (2018)
Conceptual issues of the federal state supervision reform in the sphere of circulation of drugs
Shevyrev D.N.
PDF
(Rus)
No 9 (2020)
Trend in global pharmaceutical market: COVID
Prozherina Y.
PDF
(Rus)
No 1 (2022)
Application of the ATC/DDD methodology in predicting the need for genetically engineered biological products used to treat patients with rheumatic diseases in a hospital setting
Ugoltsova V.N., Shakirova D.K., Abdulganieva D.I., Safiullin R.S.
No 12 (2019)
Advertising of prescription drugs: when you can’t have everything and even more
Borzova M.
PDF
(Rus)
No 2 (2021)
Preparing a proposal on entering a drug in the VED list: highlights
Tolkushin A.G., Kholovnya-Voloskova M.E., Pogudina N.L.
PDF
(Rus)
1 - 87 of 87 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies